These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9668390)

  • 61. Benzisoxazole- and benzisothiazole-3-carboxamides as potential atypical antipsychotic agents.
    Hrib NJ; Jurcak JG; Burgher KL; Conway PG; Hartman HB; Kerman LL; Roehr JE; Woods AT
    J Med Chem; 1994 Jul; 37(15):2308-14. PubMed ID: 7914536
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Embryonic substantia nigra grafts. Factors controlling behavioral efficacy and reinnervation of the host striatum.
    Freed WJ; Spoor HE; de Beaurepaire R; Greenberg JA; Schwarz SS
    Ann N Y Acad Sci; 1987; 495():581-96. PubMed ID: 3474960
    [No Abstract]   [Full Text] [Related]  

  • 63. A ketamine-induced rat model of tardive dyskinesia.
    Marco LA; Joshi RS
    Prog Neurobiol; 1992 Jun; 38(6):571-600. PubMed ID: 1350352
    [No Abstract]   [Full Text] [Related]  

  • 64. Stereotyped behaviour and electrocortical changes after intracerebral microinfusion of dopamine and apomorphine in fowls.
    Nisticò G; Rotiroti D; Stephenson JD
    Neuropharmacology; 1980 Oct; 19(10):963-9. PubMed ID: 7191486
    [No Abstract]   [Full Text] [Related]  

  • 65. Increased in vivo binding of 3H-pimozide in mouse striatum following repeated administration of haloperidol.
    Schwartz JC; Baudry M; Martres MP; Costentin J; Protais P
    Life Sci; 1978 Oct; 23(17-18):1785-9. PubMed ID: 569235
    [No Abstract]   [Full Text] [Related]  

  • 66. Synthesis and dopaminergic activity of some 3-(1,2,3,6-tetrahydro-1-pyridylalkyl)indoles. A novel conformational model to explain structure-activity relationships.
    Böttcher H; Barnickel G; Hausberg HH; Haase AF; Seyfried CA; Eiermann V
    J Med Chem; 1992 Oct; 35(22):4020-6. PubMed ID: 1359142
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evidence for alpha-methyl-m-tyrasmine as a false dopamine-like transmitter.
    Dorris RL; Shore PA
    J Pharm Pharmacol; 1972 Jul; 24(7):581-3. PubMed ID: 4403855
    [No Abstract]   [Full Text] [Related]  

  • 68. Apomorphine: bioavailability and effect on stereotyped cage climbing in mice.
    Smith RV; Klein AE; Wilcox RE; Riffee WH
    J Pharm Sci; 1981 Oct; 70(10):1144-7. PubMed ID: 7197717
    [TBL] [Abstract][Full Text] [Related]  

  • 69. O-methylation of apomorphine and the metabolic prolongation of apomorphine-induced stereotyped behaviour.
    Missala K; Lal S; Sourkes TL
    Eur J Pharmacol; 1973 Apr; 22(1):54-8. PubMed ID: 4735946
    [No Abstract]   [Full Text] [Related]  

  • 70. Effect of morphine on brain apomorphine concentrations in the rat.
    Symes AL; Lal S; Sourkes TL
    J Pharm Pharmacol; 1977 Jan; 29(1):44-5. PubMed ID: 13182
    [No Abstract]   [Full Text] [Related]  

  • 71. Enhanced prolactin inhibition following chronic treatment with haloperidol and morphine.
    Lal H; Brown W; Drawbaugh R; Hynes M; Brown G
    Life Sci; 1977 Jan; 20(1):101-5. PubMed ID: 556791
    [No Abstract]   [Full Text] [Related]  

  • 72. Does propofol interact with D2 dopamine receptors?
    Appadu BL; Strange PG; Lambert DG
    Anesth Analg; 1994 Dec; 79(6):1191-2. PubMed ID: 7978445
    [No Abstract]   [Full Text] [Related]  

  • 73. [In vivo binding of tritiated agents in mouse brain].
    Baudry M; Martres MP; le Sellin M; Guyon A; Morgat JL; Schwartz JC
    C R Acad Hebd Seances Acad Sci D; 1977 Oct; 285(9):1001-4. PubMed ID: 411593
    [No Abstract]   [Full Text] [Related]  

  • 74. Further identification of multiple responses mediated by dopamine in the CNS of Planorbis corneus.
    MacDonald JF; Berry MS
    Can J Physiol Pharmacol; 1978 Feb; 56(1):7-18. PubMed ID: 638860
    [No Abstract]   [Full Text] [Related]  

  • 75. Kinetic analysis of GM1 effects on haloperidol-induced dopaminergic supersensitivity.
    Palermo-Neto J; Frussa-Filho R; Vital MA
    Gen Pharmacol; 1999 Feb; 32(2):265-70. PubMed ID: 10188630
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Monosialoganglioside (GM1) attenuates the behavioural effects of long-term haloperidol administration in supersensitive rats.
    Perry JC; Vital MA; Frussa-Filho R; Tufik S; Palermo-Neto J
    Eur Neuropsychopharmacol; 2004 Mar; 14(2):127-33. PubMed ID: 15013028
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors.
    Carvalho RC; Fukushiro DF; Helfer DC; Callegaro-Filho D; Trombin TF; Zanlorenci LH; Sanday L; Silva RH; Frussa-Filho R
    Addict Biol; 2009 Jul; 14(3):283-93. PubMed ID: 19298320
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Interactions between D1 and D2 dopamine receptor family agonists and antagonists: the effects of chronic exposure on behavior and receptor binding in rats and their clinical implications.
    Braun AR; Laruelle M; Mouradian MM
    J Neural Transm (Vienna); 1997; 104(4-5):341-62. PubMed ID: 9295170
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Monosialoganglioside increased the in vivo affinity of D2 receptors for apomorphine in supersensitive rats.
    Vital MB; Frussa-Filho R; Palermo-Neto J
    Ann N Y Acad Sci; 1998 Jun; 845():428-9. PubMed ID: 9668390
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.